[Relationship between the effects of endocrinological treatment of breast cancer and the presence of estrogen receptor in the cancer tissue].
D000328:Adult; D000368:Aged; D000732:Androstanols / Q000008:administration & dosage / Q000031:analogs & derivatives; D001943:Breast Neoplasms / Q000032:analysis* / Q000628:therapy; D002369:Castration; D004054:Diethylstilbestrol / Q000008:administration & dosage*; D004338:Drug Combinations / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D011960:Receptors, Estrogen / Q000032:analysis*; D012075:Remission, Spontaneous; D013739:Testosterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D045165:Testosterone Congeners / Q000008:administration & dosage*
D000732:Androstanols; D004338:Drug Combinations; D011960:Receptors, Estrogen; D045165:Testosterone Congeners; C009588:triolandren; D013739:Testosterone; D004054:Diethylstilbestrol; C100263:dromostanolone; C007561:dromostanolone propionate
Porównanie skutków endokrynnej terapii u kobiet chorych na raka sutka z obecnościa receptora estrogenowego w tkance nowotworowej.